NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
0.0920
-0.0080 (-8.00%)
May 29, 2026, 3:58 PM AEST
ASX:NSB Market Cap
ASX:NSB has a market cap or net worth of 30.6 million as of May 29, 2026. Its market cap has increased by 306.90% in one year.
Market Cap
30.60M
Enterprise Value
24.24M
Revenue
317.91K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since July 27, 2018, ASX:NSB's market cap has increased from 16.56M to 30.60M, an increase of 84.81%. That is a compound annual growth rate of 8.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 30.60M | -16.36% |
| Dec 31, 2025 | 36.58M | 666.63% |
| Dec 30, 2024 | 4.77M | -25.00% |
| Dec 29, 2023 | 6.36M | -64.52% |
| Dec 29, 2022 | 17.93M | -62.69% |
| Dec 31, 2021 | 48.06M | 116.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entropy Neurodynamics | 53.85M |
| Nexsen | 50.05M |
| Imugene | 47.82M |
| Neurizon Therapeutics | 46.27M |
| Avecho Biotechnology | 45.97M |
| Patrys | 30.00M |
| EZZ Life Science Holdings | 29.75M |
| Noxopharm | 26.42M |